Continuous Glucose Monitoring System in Intensive Care Unit

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2013 by Seoul National University Hospital
Sponsor:
Information provided by (Responsible Party):
Jin-Tae Kim, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT01995994
First received: November 21, 2013
Last updated: November 26, 2013
Last verified: November 2013
  Purpose

To assess the accuracy, safety, and influence of sampling site of Real-time continuous glucose monitoring system (Medtronic Guardian).


Condition
Diabetic Blood Glucose Monitoring

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Continuous Glucose Monitoring System in Intensive Care Unit - Preliminary Study Evaluating Accuracy

Resource links provided by NLM:


Further study details as provided by Seoul National University Hospital:

Primary Outcome Measures:
  • Difference between finger stick blood glucose and real-time continuous glucose monitoring [ Time Frame: 72 hours ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Measurement error of real-time continuous glucose monitoring [ Time Frame: 72 hours ] [ Designated as safety issue: No ]

Estimated Enrollment: 30
Study Start Date: June 2012
Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients planned to stay in intensive care units longer than 72 hours

Criteria

Inclusion Criteria:

  • Older than 18 years old
  • Staying in intensive care units longer than 72 hours

Exclusion Criteria:

  • Skin disease
  • DIC
  • Immune suppressed patients
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01995994

Contacts
Contact: Jin-Tae Kim, MD. PhD. 82-2-2072-3295 kimjintae73@dreamwiz.com

Locations
Korea, Republic of
Seoul National University Hospital Recruiting
Seoul, Korea, Republic of, 110-744
Contact: Jin-Tae Kim, MD. PhD.    82-2-2072-3295    kimjintae73@dreamwiz.com   
Sponsors and Collaborators
Seoul National University Hospital
Investigators
Principal Investigator: Jin-Tae Kim, MD. PhD. Seoul National University Hospital
  More Information

No publications provided

Responsible Party: Jin-Tae Kim, Assistant Professor, Seoul National University Hospital
ClinicalTrials.gov Identifier: NCT01995994     History of Changes
Other Study ID Numbers: D-1203-106-404
Study First Received: November 21, 2013
Last Updated: November 26, 2013
Health Authority: Korea: Institutional Review Board

ClinicalTrials.gov processed this record on August 28, 2014